Baidu
map

智慧医疗

订阅

MedSci主页 / 所有栏目 / 智慧医疗

IBM沃森大力拓展医疗领域，6个新合作项目亮相

2015-05-14 佚名 奇点网

IBM沃森远程医疗大数据
关注

自上个月宣布推出“沃森健康部门”(Watson Health)以来，IBM一直忙个不停，陆续宣布了一系列关于其认知计算软件(沃森)在医疗保健市场的合作和部署项目。   其中大部分项目是在IBM近期于纽约召开的“沃森世界”研讨会(World of Watson)上宣布的，其中包括以下6项合作：     1. IBM沃森与梅奥诊所(Mayo Clinic

自上个月宣布推出“沃森健康部门”(Watson Health)以来，IBM一直忙个不停，陆续宣布了一系列关于其认知计算软件(沃森)在医疗保健市场的合作和部署项目。
 
其中大部分项目是在IBM近期于纽约召开的“沃森世界”研讨会(World of Watson)上宣布的，其中包括以下6项合作：
 

 
1. IBM沃森与梅奥诊所(Mayo Clinic)和Epic合作
 
沃森认知计算平台将整合Epic的电子健康记录(EHR)，允许医生利用沃森来支持临床决策，正如之前一些癌症研究中心利用沃森来帮助治疗。IBM在一份声明中称：“这项技术能够帮助开发患者治疗计划，为慢性病患者提供个性化管理，通过提供来自全球医疗研究机构的数据来帮助医生和护士，将最新的认知置于临床人员手中。”当前的整合工作仅在梅奥诊所进行，但将来会普及到所有Epic用户。
 
Epic总裁卡尔·德沃拉克(Carl Dvorak)称：“从创造性的角度讲，通过Epic平台接入沃森虚拟智能平台将为我们带来更大的能量。我们将把另一个级别的认知计算和增强智能提供给主流医疗机构，从而提升全球患者的治疗结果。”
 
2. IBM与14家肿瘤研究中心合作
 
IBM近日宣布，来自美国和加拿大的14家肿瘤中心将部署沃森计算机系统，根据患者的肿瘤基因选择适当的治疗方案。通过沃森计算系统，一个专家团队通常需要几个小时或几天来处理的数据，几分钟即可处理完毕。
 
北卡罗来纳大学Lineberger肿瘤中心主任诺曼·夏普莱斯(Norman Sharpless)称：“为癌症患者确定适当的药物组合是一件相当困难的事情，需要对不同的大数据源进行复杂的分析。我们与IBM合作就是希望利用沃森的认知技术来解决该问题，尽可能地提高患者治愈率。”
 
此次与IBM合作的14家肿瘤研究所分别为：芝加哥安妮和罗伯特·卢里儿童医院、BC Cancer Agency、希望之城(City of Hope)、 克利夫兰医学中心、杜克肿瘤研究所、弗莱德和帕梅拉巴菲特肿瘤中心、圣路易斯华盛顿大学麦克唐奈基因组研究所、纽约基因组中心、斯坦福健康(Sanford Health)、勘萨斯大学肿瘤中心、北卡罗来纳大学Lineberger肿瘤中心、南加州大学应用分子医学中心、华盛顿大学医学中心和耶鲁肿瘤中心。
 
3. 科罗拉多州健康系统采用CafeWell Concierge应用
 
科罗拉多州的Centura Health心脏和血管网络(CHHVN)将率先部署CafeWell Concierge应用。该应用基于沃森平台，由健康管理应用开发商Welltok开发，是专为消费者设计的个人医疗指导程序。它利用沃森的认知计算能力来理解复杂的人类语言，在几秒内从数以百万计的大数据中找出有用的答案，如每日健康管理、慢性病康复训练和查找本地餐馆内的健康食谱等。
 
4. Talkspace利用沃森帮助患者匹配治疗师
 
文本疗法创业公司Talkspace将利用沃森来分析其用户发送的短信，找出用户的倾向和喜好，帮助他们找到最适合的治疗师。Talkspace的平台是一种基于文本信息的疗法，旨在让超过4500万被诊断为心理健康问题的患者找到匹配的治疗师。
 
5. LifeLearn将沃森引入兽医市场
 
LifeLearn公司正通过一款由沃森提供技术支持的应用“Sofie”改变兽医的发展趋势，它可以帮助兽医在治疗动物时识别潜在病情，并基于实例开出处方。亚伯丁兽医诊所(Aberdeen Veterinary Clinic)目前正在使用该应用。
 
6. hc1.com利用沃森提升患者互动
 
hc1.com通过由沃森提供技术支持的应用“hc1 Patient Insights”提供高度个性化的患者护理与服务，它可以分析患者交互信息，并依此定制未来的互动。目前印第安纳波利斯医疗保健公司Eskenazi Health正在使用该应用。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719864, encodeId=96fc1e198648b, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Fri Jul 17 05:25:00 CST 2015, time=2015-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23897, encodeId=9f232389e9c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:58:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489921, encodeId=6fbd148992197, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621478, encodeId=97da16214e82c, content=<a href='/topic/show?id=82519314a5' target=_blank style='color:#2F92EE;'>#IBM沃森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9314, encryptionId=82519314a5, topicName=IBM沃森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d0520274481, createdName=yese, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23575, encodeId=e13e235e57f, content=图片好漂亮，呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Fri May 15 08:07:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23551, encodeId=14142355139, content=还是肿瘤厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 23:12:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-07-17 zsyan

    #医疗领域#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1719864, encodeId=96fc1e198648b, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Fri Jul 17 05:25:00 CST 2015, time=2015-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23897, encodeId=9f232389e9c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:58:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489921, encodeId=6fbd148992197, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621478, encodeId=97da16214e82c, content=<a href='/topic/show?id=82519314a5' target=_blank style='color:#2F92EE;'>#IBM沃森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9314, encryptionId=82519314a5, topicName=IBM沃森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d0520274481, createdName=yese, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23575, encodeId=e13e235e57f, content=图片好漂亮，呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Fri May 15 08:07:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23551, encodeId=14142355139, content=还是肿瘤厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 23:12:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-17 huaxipanxing

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1719864, encodeId=96fc1e198648b, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Fri Jul 17 05:25:00 CST 2015, time=2015-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23897, encodeId=9f232389e9c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:58:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489921, encodeId=6fbd148992197, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621478, encodeId=97da16214e82c, content=<a href='/topic/show?id=82519314a5' target=_blank style='color:#2F92EE;'>#IBM沃森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9314, encryptionId=82519314a5, topicName=IBM沃森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d0520274481, createdName=yese, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23575, encodeId=e13e235e57f, content=图片好漂亮，呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Fri May 15 08:07:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23551, encodeId=14142355139, content=还是肿瘤厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 23:12:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-16 tulenzi

    #IBM#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1719864, encodeId=96fc1e198648b, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Fri Jul 17 05:25:00 CST 2015, time=2015-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23897, encodeId=9f232389e9c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:58:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489921, encodeId=6fbd148992197, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621478, encodeId=97da16214e82c, content=<a href='/topic/show?id=82519314a5' target=_blank style='color:#2F92EE;'>#IBM沃森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9314, encryptionId=82519314a5, topicName=IBM沃森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d0520274481, createdName=yese, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23575, encodeId=e13e235e57f, content=图片好漂亮，呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Fri May 15 08:07:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23551, encodeId=14142355139, content=还是肿瘤厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 23:12:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-16 yese

    #IBM沃森#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1719864, encodeId=96fc1e198648b, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Fri Jul 17 05:25:00 CST 2015, time=2015-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23897, encodeId=9f232389e9c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:58:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489921, encodeId=6fbd148992197, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621478, encodeId=97da16214e82c, content=<a href='/topic/show?id=82519314a5' target=_blank style='color:#2F92EE;'>#IBM沃森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9314, encryptionId=82519314a5, topicName=IBM沃森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d0520274481, createdName=yese, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23575, encodeId=e13e235e57f, content=图片好漂亮，呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Fri May 15 08:07:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23551, encodeId=14142355139, content=还是肿瘤厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 23:12:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-15 吴颖

    图片好漂亮，呵呵

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1719864, encodeId=96fc1e198648b, content=<a href='/topic/show?id=d49a35211c8' target=_blank style='color:#2F92EE;'>#医疗领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35211, encryptionId=d49a35211c8, topicName=医疗领域)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c6a32837966, createdName=zsyan, createdTime=Fri Jul 17 05:25:00 CST 2015, time=2015-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23897, encodeId=9f232389e9c, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 17 19:58:00 CST 2015, time=2015-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489921, encodeId=6fbd148992197, content=<a href='/topic/show?id=f91c93134e' target=_blank style='color:#2F92EE;'>#IBM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9313, encryptionId=f91c93134e, topicName=IBM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0288649873, createdName=tulenzi, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621478, encodeId=97da16214e82c, content=<a href='/topic/show?id=82519314a5' target=_blank style='color:#2F92EE;'>#IBM沃森#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9314, encryptionId=82519314a5, topicName=IBM沃森)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d0520274481, createdName=yese, createdTime=Sat May 16 13:25:00 CST 2015, time=2015-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23575, encodeId=e13e235e57f, content=图片好漂亮，呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K3r6Ir8EADbw8kut6NgpfYKrksLd7rsf9GSZGCUZkpHosu8Jsibzk64KSuO8dFfOW7J5kW4bjib4eI/0, createdBy=d0201619051, createdName=吴颖, createdTime=Fri May 15 08:07:00 CST 2015, time=2015-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=23551, encodeId=14142355139, content=还是肿瘤厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Thu May 14 23:12:00 CST 2015, time=2015-05-14, status=1, ipAttribution=)]
    2015-05-14 hbwang006

    还是肿瘤厉害

    0

Baidu
map
Baidu
map
Baidu
map